In-utero treatment of large symptomatic rhabdomyoma with sirolimus

Ultrasound Obstet Gynecol. 2019 Mar;53(3):420-421. doi: 10.1002/uog.20196.

Authors

C Vachon-Marceau¹, V Guerra², E Jaeggi², V Chau³, G Ryan¹, T Van Mieghem¹

Affiliations

¹ Department of Obstetrics and Gynaecology, Fetal Medicine Unit, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
² Department of Pediatric Cardiology, Hospital for Sick Children and University of Toronto, Toronto, Canada.
³ Department of Pediatric Neurology, Hospital for Sick Children and University of Toronto, Toronto, Canada.

PMID: 30549350
DOI: 10.1002/uog.20196

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Echocardiography / methods*
Female
Fetal Diseases / diagnostic imaging
Fetal Diseases / pathology
Heart Neoplasms / diagnostic imaging*
Heart Neoplasms / pathology
Humans
Infant, Newborn
Magnetic Resonance Imaging / methods
Male
Pericardial Effusion / complications
Pregnancy
Rhabdomyoma / complications
Rhabdomyoma / diagnostic imaging*
Rhabdomyoma / pathology
Sirolimus / administration & dosage*
Sirolimus / therapeutic use
TOR Serine-Threonine Kinases / antagonists & inhibitors
Treatment Outcome

Substances

MTOR protein, human
TOR Serine-Threonine Kinases
Sirolimus